Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Photodynamic Therapy Market From 2025 to 2029?

Recent years have seen a powerful surge in the market size of photodynamic therapy. The market is projected to expand from $1.45 billion in 2024 to $1.53 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.6%. Various factors have contributed to this growth during the historic period, including a growing aging population, the surge in cancer cases, an upswing in skin diseases, escalating pollution levels, an enhancement in healthcare expenditure, and an increase in the number of healthcare facilities.

The photodynamic therapy market is projected to experience robust growth in the coming years, reaching a value of “$1.93 billion by 2029 with a compound annual growth rate (CAGR) of 6.0%.” The forecast period’s expansion is linked to factors like increased healthcare spending, insurance plans covering photodynamic therapy, untapped potential in developing economies, growing teenage and elderly demographics, a surge in cancer and chronic disease cases, and the emergence of infectious diseases. Key trends during this period are expected to include the launch of portable photodynamic therapy devices for at-home skin PDT treatments, investment in AI-driven PDT to enhance patient care, expanding product range in the cosmetic procedure sector, sustained investment in research and development, and an emphasis on introducing photoimmunotherapy devices and including photothermal therapy in the portfolio.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What Elements Are Contributing To Growth In The Photodynamic Therapy Market?

The escalating occurrence of skin cancer is instrumental in driving the growth of the market for photodynamic therapy. Skin cancer is noted as the most prevalent amongst all forms of cancer. Melanoma, although constituting approximately just 1% of skin cancers, is associated with a significant number of skin cancer fatalities. Photodynamic therapy (PDT) leverages a light-sensitizing medication and intensive light to eradicate cancerous cells. The practitioner applies a lotion containing a light-sensitizing chemical to the skin cancer and the vicinity surrounding it. For example, in January 2024, the American Cancer Society, a professional organization based in the US, stated that skin cancer is the primary cancer in the US, with melanoma accounting for around 1% of cases, but responsible for most skin cancer deaths. Additionally, around 100,640 novel melanoma cases are anticipated to be diagnosed in 2024 in the US, of which roughly 59,170 are expected in men and 41,470 in women. Approximately 8,290 melanoma-associated deaths are also projected, which include around 5,430 men and 2,860 women. Consequently, the rising rates of skin cancer are foreseen to stimulate the growth of the photodynamic therapy market in the future years.

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Notable Trends Are Shaping The Direction Of The Photodynamic Therapy Market?

The photodynamic therapy market’s participants are paying increasing attention to clinical trials involving various drug combinations for PDT. Kintara Therapeutics, a biotech company based in the US, for instance, kick-started a clinical trial for their REM-001 therapy, aimed at cutaneous metastatic breast cancer, in February 2024. The clinical trial, NCT05374915, is an open-label study with 15 participants suffering from cutaneous metastatic breast cancer (CMBC). The trial, which evaluates the second-generation photodynamic therapy agent REM-001 with a dosage of 0.8 mg, is designed to enhance the study setup before a Phase 3 trial. The main focus is on the Best Overall Objective Response Rate (bORR) in the treatment areas within 24 weeks and the primary endpoint revolves around the measurement of complete and partial responses.

Who Are The Key Contributors To Growth In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Region Is Projected To Lead The Photodynamic Therapy Market By 2025?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model